Exane Derivatives Tg Therapeutics, Inc. Transaction History

Exane Derivatives

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$3.74 - $10.66 $21,112 - $60,175	-5,645 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$7.81 - $20.45 $44,087 - $115,440	5,645 New	5,645 $53,000
Q4 2021 Jan 28, 2022	SELL	$15.2 - $35.51 $81,593 - $190,617	-5,368 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$21.78 - $40.45 $77,602 - $144,123	-3,563 Reduced 39.89%	5,368 $178,000
Q1 2021 Apr 30, 2021	SELL	$41.61 - $54.3 $110,308 - $143,949	-2,651 Reduced 22.89%	8,931 $430,000
Q4 2020 Jan 27, 2021	BUY	$25.27 - $54.9 $32,547 - $70,711	1,288 Added 12.51%	11,582 $602,000
Q3 2020 Oct 08, 2020	BUY	$18.49 - $27.24 $190,336 - $280,408	10,294 New	10,294 $275,000
Q3 2020 Oct 06, 2020	SELL	$18.49 - $27.24 $269,584 - $397,159	-14,580 Closed	0 $0
Q2 2020 Jul 10, 2020	SELL	$8.9 - $21.84 $34,336 - $84,258	-3,858 Reduced 20.92%	14,580 $284,000
Q1 2020 Apr 17, 2020	BUY	$7.14 - $15.99 $128,541 - $287,867	18,003 Added 4138.62%	18,438 $181,000
Q3 2018 Oct 24, 2018	SELL	$5.15 - $14.0 $48,404 - $131,586	-9,399 Reduced 95.58%	435 $0
Q2 2018 Oct 24, 2018	BUY	$12.5 - $15.0 $122,925 - $147,510	9,834 New	9,834 $0
Q2 2018 Jul 19, 2018	SELL	$12.5 - $15.0 $122,925 - $147,510	-9,834 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$8.7 - $16.8 $85,555 - $165,211	9,834 New	9,834 $0

349

89.5M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.61B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.